Krystal Biotech, Inc. (KRYS) Operating income 2016–2025
Krystal Biotech, Inc. (KRYS) annual operating income history from SEC filings — each fiscal year as reported.
$161.3MFY2025 · since FY2016: -$1.1M → $161.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $161.3M | +145.3% |
| FY2024 | $65.7M | +160.0% |
| FY2023 | -$109.6M | +24.5% |
| FY2022 | -$145.2M | -112.7% |
| FY2021 | -$68.3M | -106.9% |
| FY2020 | -$33.0M | -49.4% |
| FY2019 | -$22.1M | -85.3% |
| FY2018 | -$11.9M | -149.7% |
| FY2017 | -$4.8M | -317.5% |
| FY2016 | -$1.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice